Utilisation d'un gel de prostaglandine F 2-alpha pour l'interruption de grossesse et l'evacuation de mort in utero au cours du 2eme trimestre. [Prostaglandin F-2-alpha gel for induction of midtrimester abortion (author's transl)]

Détails

ID Serval
serval:BIB_F38432DA8FE1
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Utilisation d'un gel de prostaglandine F 2-alpha pour l'interruption de grossesse et l'evacuation de mort in utero au cours du 2eme trimestre. [Prostaglandin F-2-alpha gel for induction of midtrimester abortion (author's transl)]
Périodique
Journal de Gynécologie, Obstétrique et Biologie de la Reproduction
Auteur⸱e⸱s
De Grandi  P., Nguyen The  H., Suppan  P., Kunz  B.
ISSN
0368-2315 (Print)
Statut éditorial
Publié
Date de publication
08/1979
Volume
8
Numéro
5
Pages
455-62
Notes
English Abstract
Journal Article --- Old month value: Jul-Aug
Résumé
Prostaglandin F2-alpha was administered extra-amniotic as a gel through the cervix uteri to 100 patients in the 2nd trimester of pregnancy: 82 for termination of pregnancy, 17 for intrauterine death, and 1 for a hydatiform mole. The success rate was 96 p. 100. Mean duration of induction was 17 hrs 06 min., cervical priming lowered this duration to 11 hrs 40 min. (p less than 0.01). Extradural analgesia provided satisfactory pain relief and allowed a dilatation and curettage to be performed without recoure to a general anaesthetic. The technique described showed a lower incidence of side-effects than other modes of administration of PG F2-alpha, and proved to be effective, reliable, and acceptable to patients.
Mots-clé
*Abortion, Induced Cervix Uteri Female Fetal Death Gels Humans Hydatidiform Mole Pregnancy *Pregnancy Trimester, Second Prostaglandins F/administration & dosage/*therapeutic use
Pubmed
Web of science
Création de la notice
25/01/2008 16:40
Dernière modification de la notice
20/08/2019 17:20
Données d'usage